Freedom from Structural Valve Deterioration
Author | Year | No. of Patients |
Type of Study |
Type of Valve |
Mean Follow-Up (yrs) |
5 years (%) |
10 years (%) |
15 years (%) |
20 years (%) |
25 years (%) |
Linearized rate (% per pt year) |
---|---|---|---|---|---|---|---|---|---|---|---|
Butchart et al, | 2001 | 796 | Prospective Follow-Up | Medtronic Hall | 7.6 | - | 100 | 100 | - | - | 0 |
Khan et al, | 2001 | 513 | Prospective Follow-Up | St. Jude Medical | * | 100 | 100 | 100 | - | - | 0 |
Remadi et al, | 2001 | 440 | Retrospective | St. Jude Medical | 19 | - | - | - | 100% (19yr) | - | 0 |
Murday et al, | 2003 | 61 | Prospective Randomized Trial | St. Jude Medical | 8 | - | - | - | - | - | - |
Borman et al, | 2003 | 656 | Retrospective Multicenter | Sorin Bicarbon | 4.6 | - | 100 (8yr) | - | - | - | 0 |
Tominaga et al, | 2005 | 253 | Prospective Follow-Up | Carbomedics | 5.1 | - | 100 | - | - | - | 0 |
Baykut et al, | 2006 | 168 | Retrospective | ATS | 4.3 | 100 | 100 | - | - | - | 0 |
Wu et al, | 2006 | 196 | Prospective Follow-Up | Carbomedics | 4.6 | - | - | - | - | - | - |
Aoyagi et al, | 2007 | 115 | Retrospective | ATS | 4.2 | 100 | 100 (7yr) | - | - | - | 0 |
Bryan et al, | 2007 | 75 | Prospective Randomized Trial | Carbomedics | 10 | 100 | 100 | - | - | - | 0 |
Bryan et al, | 2007 | 85 | Prospective Randomized Trial | St. Jude Medical | 10 | 100 | 100 | - | - | - | 0 |
Spiliopoulos et al, | 2009 | 122 | Prospective Follow-Up | Sorin Bicarbon | 9.8 | 100 | 100 | - | - | - | 0 |
Azarnoush et al, | 2010 | 586 | Prospective Follow-Up | Sorin Bicarbon | 10.2 | 100 | 100 | 100 | - | - | 0 |
Toole et al, | 2010 | 408 | Prospective Follow-Up | St. Jude Medical Standard, Masters, HP, and Regent | 9 | 100 | 100 | 100 | 100 | 100 | 0 |
Aaron J. Weiss M.D., Stephen M. Spindel M.D., and Farzan Filsoufi M.D.
- Butchart EG, Li HH, Payne N, et al. Twenty years' experience with the Medtronic Hall valve. J Thorac Cardiovasc Surg 2001;121:1090-100.
- Khan SS, Trento A, DeRobertis M, et al. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 2001;122:257-69.
- Remadi JP, Baron O, Roussel C, et al. Isolated mitral valve replacement with St. Jude medical prosthesis: long-term results: a follow-up of 19 years. Circulation 2001;103:1542-5.
- Murday AJ, Hochstitzky A, Mansfield J, et al. A prospective controlled trial of St. Jude versus Starr Edwards aortic and mitral valve prostheses. Ann Thorac Surg 2003;76:66-73; discussion 73-4.
- Borman JB, De Riberolles C. Sorin Bicarbon bileaflet valve: a 10-year experience. Eur J Cardiothorac Surg 2003;23:86-92.
- Tominaga R, Kurisu K, Ochiai Y, et al. A 10-year experience with the Carbomedics cardiac prosthesis. Ann Thorac Surg 2005;79:784-9.
- Baykut D, Grize L, Schindler C, et al. Eleven-year single-center experience with the ATS Open Pivot Bileaflet heart valve. Ann Thorac Surg 2006;82:847-52.
- Wu Y, Gao G, Mody S, et al. Update of the Providence Health System experience with the CarboMedics prosthesis. J Heart Valve Dis 2006;15:414-20.
- Aoyagi S, Hori H, Yoshikawa K, et al. Mid-term results of valve replacement with the ATS valve: a seven-year follow up. J Heart Valve Dis 2007;16:267-74.
- Bryan AJ, Rogers CA, Bayliss K, et al. Prospective randomized comparison of CarboMedics and St. Jude Medical bileaflet mechanical heart valve prostheses: ten-year follow-up. J Thorac Cardiovasc Surg 2007;133:614-22.
- Spiliopoulos K, Haschemi A, Parasiris P, et al. Sorin Bicarbon bileaflet valve: a 9.8-year experience. Clinical performance of the prosthesis after heart valve replacement in 587 patients. Interact Cardiovasc Thorac Surg 2009;8:252-9.
- Azarnoush K, Laborde F, de Riberolles C. The Sorin Bicarbon over 15 years clinical outcomes: multicentre experience in 1704 patients. Eur J Cardiothorac Surg 2010;38:759-66.
- Toole JM, Stroud MR, Kratz JM, et al. Twenty-five year experience with the St. Jude medical mechanical valve prosthesis. Ann Thorac Surg 2010;89:1402-9.